He received his medical education in China and doctoral education at Karolinska Institute in Sweden. Dr Li’s main research interests are thrombotic and inflammatory mechanisms in atherosclerosis, platelet angiogenetic activities in arterial remodelling and cancer progression, and clinical evaluation of anti-platelet drugs. He is an internationally recognised researcher in platelet functional studies and platelet-T effector cell interactions.